Nobel Prize awarded for discoveries that could improve cancer treatment, other top stories in oncology
Click Here to Manage Email Alerts
The announcement that William G. Kaelin Jr., MD, Sir Peter J. Ratcliffe, MD, and Gregg L. Semenza, MD, PhD, were awarded the Nobel Prize in Physiology or Medicine for their discoveries of how cells sense and adapt to oxygen availability was the top story in oncology last week.
Other top stories included the FDA’s decision to fast track navicixizumab for pretreated ovarian cancer and to award $15 million in grants to fund clinical trials for treatments for rare diseases.
Researchers share Nobel Prize for discoveries that may improve treatment of cancer, anemia
Three scientists — two from the United States and one from England — have been awarded the Nobel Prize in Physiology or Medicine for their discoveries of how cells sense and adapt to oxygen availability. Read more.
FDA grants fast track designation to navicixizumab for pretreated ovarian cancer
The FDA granted fast track designation to navicixizumab for the treatment of women with heavily pretreated high-grade ovarian, primary peritoneal or fallopian tube cancer. Read more.
FDA awards $15 million to fund trials of treatments for rare diseases
The FDA awarded 12 grants worth more than $15 million to fund clinical trials of medical products intended to treat patients with rare diseases. Read more.
Malnutrition common among older patients with cancer
Hospitalized older patients with cancer demonstrated higher risk for malnutrition compared with their younger counterparts, according to results of a prospective Brazilian study published in Cancer. Read more.
Molecular test shows potential for faster breast cancer diagnosis
A novel molecular test developed by researchers at Johns Hopkins Kimmel Cancer Center demonstrated the ability to quickly and accurately distinguish between malignant and benign breast tumors. Read more.